Status:
UNKNOWN
Evaluation of Post-ERCP Pain as a Predictor for Post-ERCP Pancreatitis
Lead Sponsor:
Nicola Frei
Conditions:
Post-ERCP Acute Pancreatitis
Eligibility:
All Genders
18+ years
Brief Summary
Pancreatitis is the most common complication after ERCP, although its frequency varies significantly depending on the study from \< 2% up to 40%. Based upon data from studies that have included unsel...
Eligibility Criteria
Inclusion
- Age \>18 years
- Scheduled for ERCP for any reason
Exclusion
- Absence of consent
- Language barrier
- No endoscopic advance to the papilla vateri
- Active pancreatitis at the time of the procedure
- Mental disability
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2023
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04770857
Start Date
September 1 2021
End Date
August 1 2023
Last Update
July 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kantonsspital Sankt Gallen
Sankt Gallen, Switzerland, 9007